Forus Health

About Forus Health

We are a pioneering force in medical technology, dedicated to redefining the future of eye care through precision and innovative technology. We are committed to improving ocular disease management through early detection and accurate diagnosis, enabling healthcare professionals to deliver better outcomes more efficiently. Our flagship 3nethra Series is a true embodiment of this vision. From the Classic HD to the ultra-portable Pico handheld retinal imaging systems for adult care, each device is engineered to deliver exceptional image clarity and reliability. In neonatal care, our 3nethra neo and neo HD FA stand among the most advanced retinal imaging solutions available globally, setting new benchmarks in precision and safety. Complementing this portfolio, our 3nethra aberro and Specto devices redefine both objective and subjective refraction, offering unmatched accuracy across diverse diagnostic requirements. We are at the forefront of AI-driven healthcare innovation with FH-POISE™, an advanced platform that integrates high-resolution ocular imaging with clinically validated algorithms for precise detection and management of ocular and systemic conditions. Our AI enables identification of diabetic retinopathy, glaucoma, ARMD, hypertensive retinopathy, and dry eye through advanced retinal analytics, transforming retinal data into actionable insights and redefining diagnostic excellence. Looking ahead, we are pioneering the use of retinal biomarkers to assess systemic conditions—including cardiovascular, neurological, nephrological, and autoimmune diseases—unlocking new possibilities in predictive and preventive healthcare. With a global footprint spanning over 5000+ installations across more than 85 countries, we have positively impacted more than 25 million lives—bringing high-quality, accessible eye care to underserved and advanced markets alike. Our seamlessly integrated ecosystem enables healthcare professionals to deliver comprehensive care worldwide.